During the past decade, Virginia Commonwealth University Medical Center conducted 99 clinical trials. In the 10-year time frame, 99 clinical trials started and 78 clinical trials were completed, i.e. on average, 78.8% percent of trials that started reached the finish line to date. In the past 5 years, 45 clinical trials started and 43 clinical trials were completed. i.e. 95.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Virginia Commonwealth University Medical Center" #1 sponsor was "Virginia Commonwealth University" with 25 trials, followed by "Boston Scientific Corporation" with 10 trials sponsored, "Gilead Sciences" with 9 trials sponsored, "Medical College of Wisconsin" with 9 trials sponsored and "Medtronic Cardiac Rhythm and Heart Failure" with 9 trials sponsored. Other sponsors include 149 different institutions and companies that sponsored additional 118 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Commonwealth University Medical Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 19 trials as a collaborator, "Blood and Marrow Transplant Clinical Trials Network" with 13 trials as a collaborator, "National Cancer Institute (NCI)" with 13 trials as a collaborator, "National Marrow Donor Program" with 9 trials as a collaborator and "Medical University of South Carolina" with 6 trials as a collaborator. Other collaborators include 98 different institutions and companies that were collaborators in the rest 82 trials.

According to Clinical.Site data, the most researched conditions in "Virginia Commonwealth University Medical Center" are "Heart Failure" (11 trials), "Atrial Fibrillation" (6 trials), "COVID-19" (6 trials), "Pulmonary Hypertension" (5 trials) and "Sickle Cell Disease" (5 trials). Many other conditions were trialed in "Virginia Commonwealth University Medical Center" in a lesser frequency.

Most popular intervention types in "Virginia Commonwealth University Medical Center" are "Drug" (111 trials), "Device" (51 trials), "Biological" (20 trials), "Other" (16 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (37 trials), "Tacrolimus" (5 trials), "brentuximab vedotin" (5 trials), "Remdesivir" (4 trials) and "Cyclophosphamide" (3 trials). Other intervention names were less common.

The vast majority of trials in "Virginia Commonwealth University Medical Center" are 207 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Virginia Commonwealth University Medical Center". undefined are not yet recruiting, 28 are recruiting, 22 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 109 completed trials in Virginia Commonwealth University Medical Center, 2 suspended trials, and 37 terminated clinical trials to date.

Out of the total trials that were conducted in Virginia Commonwealth University Medical Center, 10 "Phase 1" clinical trials were conducted, 49 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 43 trials that are defined as “Not Applicable".

Virginia Commonwealth University Medical Center has several departments that took part in Clinical trials: "VCU Health System Endoscopy Suite" - 3 trials, "VCU Health System Digestive Health Center" - 3 trials, "VCU Outpatient Psychiatry Clinic" - 2 trials